Wadhane Jitendra bought PYXS
March 24, 2026 · Form 4 insider transaction
Wadhane Jitendra bought 262,635 shares of Pyxis Oncology, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
262,635
Price
$0.00
Total value
N/A
InsiderWadhane Jitendra
RoleOfficer
CompanyPyxis Oncology, Inc. (PYXS)
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateMarch 24, 2026
Filing dateMarch 25, 2026
Shares owned after262,635
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The shares subject to this option will vest over four years, with 25% vesting on the first anniversary of March 24, 2026 and the remainder vesting in 36 equal monthly installments thereafter, subject to the reporting person's continued emmployment through the applicable vesting date.